Founders stepping aside for outside CEOs and then returning as CEO later on is quite a trope in the tech world, and Daniel ...

Learn more about whether Appian Corporation or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time ...

Learn more about whether CleanSpark, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a ...

UiPath focuses on agentic automation, boasts a large ARR base, and has high gross margins. Click here to read why PATH stock ...

Leading CISOs honored for leadership, security, and business impact SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- The 2025 ...

PATH's ARR growth decelerated for 12 consecutive quarters, with net-new ARR down 31% y/y in 4Q25, indicating poor revenue ...

UiPath (NYSE:PATH) recently launched its AI-based Medical Record Summarization Agent at the Google Cloud Next 2025 event, emphasizing efficiency and cost savings in healthcare. Despite these promising ...

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

UiPath shares rise on launch of generative AI-based UiPath Medical Record Summarization agent at Google Cloud Next 2025.

UiPath (PATH) announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by ...